Cargando…
MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma
INTRODUCTION: Glioblastoma (GBM) is a highly aggressive and lethal primary brain tumor. Despite limited treatment options, the overall survival of GBM patients has shown minimal improvement over the past two decades. Factors such as delayed cancer diagnosis, tumor heterogeneity, cancer stem cell sur...
Autores principales: | Grafals-Ruiz, Nilmary, Sánchez-Álvarez, Annelis O., Santana-Rivera, Yasmarie, Lozada-Delgado, Eunice L., Rabelo-Fernandez, Robert J., Rios-Vicil, Christian I., Valiyeva, Fatima, Vivas-Mejia, Pablo E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518455/ https://www.ncbi.nlm.nih.gov/pubmed/37752997 http://dx.doi.org/10.3389/fonc.2023.1249649 |
Ejemplares similares
-
Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
por: Grafals-Ruiz, Nilmary, et al.
Publicado: (2020) -
Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression
por: Lozada-Delgado, Eunice L., et al.
Publicado: (2018) -
Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022) -
Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022) -
Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer
por: Noriega-Rivera, Ricardo, et al.
Publicado: (2022)